Universitäres Centrum für Tumorerkrankungen Mainz (UCT Mainz)
Klinisch orientierter Schwerpunkt / Johannes Gutenberg-Universität Mainz
Battista, Marco Johannes; Anic, Katharina; Linz, Valerie et al.
The impact of different global health assessment tools on the prognosis of older ovarian cancer patients-results of a retrospective single institution cohort studyZEITSCHRIFT FUR GERONTOLOGIE UND GERIATRIE. Bd. 56. 2023 S. S3-S4
Singer, Susanne; Sykiotis, Gerasimos; Al-Ibraheem, Akram et al.
The impact of electronic versus paper-based data capture on data collection logistics and on missing scores in thyroid cancer patientsENDOCRINE. 2023
Scobioala, Sergiu; Parfitt, Ross; Matulat, Peter et al.
The impact of the temporal sequence of cranial radiotherapy and platin-based chemotherapy on hearing impairment in pediatric and adolescent CNS and head-and-neck cancer patients: A report from the PanCareLIFE consortiumINTERNATIONAL JOURNAL OF CANCER. 2023
Oertel, Michael; Berdel, Christian; Held, Gerhard et al.
The new German evidence-based guideline on diffuse large B-cell lymphoma-key aspects for radiation oncologistsSTRAHLENTHERAPIE UND ONKOLOGIE. Bd. 199. H. 2. 2023 S. 115-120
Loeffler, Marius; Friedrich, Maria; Shehaj, Inna et al.
THE PROGNOSTIC RELEVANCE OF THE LYMPH NODE RATIO IN PRIMARY ENDOMETRIAL CANCERANTICANCER RESEARCH. Bd. 43. H. 7. 2023 S. 3370-3370
More, Piyush; Ngaffo, Joelle Aurelie Mekontso; Goedtel-Armbrust, Ute et al.
Transcriptional Response to Standard AML Drugs Identifies Synergistic CombinationsINTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. Bd. 24. H. 16. 2023
Klar, Maximilian; Plett, Helmut; Harter, Philipp et al.
Treatment and survival of patients with malignant ovarian sex cord-stromal cell tumours: An analysis of the Arbeitsgemeinschaft fu''r Gynakologische Onkologie (AGO) study group CORSETT databaseJOURNAL OF SURGICAL ONCOLOGY. Bd. 128. H. 1. 2023 S. 111-118
Decker, T.; Brucker, C.; Engel, A. et al.
Treatment of elderly patients (pts; > 75 years) with 1st line ribociclib (RIB) plus aromatase inhibitor (AI)/fulvestrant (FUL) or endocrine monotherapy (ET) in clinical routine: Real-world data from the RIBANNA study (5th interim analysis (IA))ONCOLOGY RESEARCH AND TREATMENT. Bd. 46. 2023 S. 168-169
Decker, T.; Brucker, C.; Fasching, P. et al.
Treatment of elderly patients (pts; > 75 years) with 1st-line ribociclib (RIB) plus endocrine therapy (ET) or endocrine monotherapy in clinical routine: Real-world data from the RIBANNA study (5th interim analysis (IA))ANNALS OF ONCOLOGY. Bd. 34. 2023 S. S354-S355
Roser, Eva; Harter, Philipp; Zocholl, Dario et al.
Treatment strategies in patients with gynecological sarcoma: Results of the prospective intergroup real-world registry for gynecological sarcoma in Germany (REGSA-NOGGO RU1)INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER. 2023